For many patients grappling with long COVID, the enduring loss of taste has remained one of the most frustrating and mysterious symptoms. Now, a new study finally provides the "smoking gun" for this condition. By performing biopsies on human taste buds, scientists have identified a specific molecular defect—a drastic reduction in the messenger RNA for a crucial protein called PLCβ2—that explains why some people still cannot properly taste their food long after recovering from the initial infection.
The study, published in the journal Chemical Senses in March 2026, was conducted by an international team of researchers from the University of Colorado Anschutz Medical Campus and two Swedish universities. The research team, which included Dr. Hanna Morad, Dr. Göran Hellekant, and Professor Thomas E. Finger, analyzed 28 non-hospitalized patients who reported persistent taste disturbances more than a year after contracting COVID-19. By taking biopsies of the patients' taste buds, the researchers were able to investigate the molecular and structural changes occurring at the cellular level.
The defining discovery of the study centers on the protein Phospholipase C beta 2 (PLCβ2). In a healthy gustatory system, PLCβ2 acts as a vital signal amplifier inside the taste cells specifically responsible for detecting sweet, bitter, and umami (savory) flavors.
"It strengthens the signal before it's transmitted to the brain," explained Professor Thomas E. Finger from the University of Colorado Anschutz. "When levels are reduced, the taste signal weakens". Without sufficient PLCβ2, the "volume" of taste signals is turned down so low that the brain simply cannot detect them.
Crucially, because the receptors for salty and sour flavors rely on simple ion channels rather than this complex protein relay system, those specific tastes are largely preserved in these patients. This selective biological mechanism directly explains why many long COVID patients report being able to taste salt and vinegar, but not coffee or chocolate.
Furthermore, the biopsies provided clear evidence that the virus itself is no longer the immediate culprit. The researchers detected no viral RNA in the tissue samples, indicating that the lingering symptoms are not caused by an ongoing, hidden infection in the mouth. Instead, the issue lies in the cellular signaling machinery.
While normal taste bud cells are replaced every two to four weeks, the "progenitor" cells responsible for making new taste cells in these long COVID patients appear to be producing "faulty" versions that lack the necessary PLCβ2 protein. Alongside this molecular defect, the researchers also observed architectural changes in the sensory tissue. "Some subjects had normal-looking taste buds, while others showed structural disorganization," Finger noted, suggesting that both molecular and structural damage contribute to the dysfunction.
Currently, there is no immediate cure for long COVID taste loss. However, by identifying the specific missing protein, this breakthrough offers the first direct biological evidence of the underlying cause. Scientists can now use this "smoking gun" to begin exploring targeted therapies—such as topical treatments or specific medications—designed to jumpstart the production of PLCβ2 and finally restore flavor to those who have been living without it.